Hepatectomy versus sorafenib for advanced hepatocellular carcinoma with macroscopic portal vein tumor thrombus: A bi‐institutional propensity‐matched cohort study — Shohei Komatsu (2022) | RDL Network
Hepatectomy versus sorafenib for advanced hepatocellular carcinoma with macroscopic portal vein tumor thrombus: A bi‐institutional propensity‐matched cohort study
Article 2022 en
Authors
SK
Shohei Komatsu
KU
Kazuomi Ueshima
MK
Masahiro Kido
Abstract
1 min read
Hepatectomy can be associated with prolonged survival in HCC patients with macroscopic PVTT.
Jessica Howell, David J. Pinato, Ramya Ramaswami, Dominik Bettinger, Tadaaki Arizumi, Cecilia Ferrari, Clarence Yen, Antonello Gibbin, Michela Emma Burlone, Giulia Guaschino, L. Sellers, James R. Black, Mario Pirisi, Masatoshi Kudo, Robert Thimme, J.‐W. Park, Rohini Sharma
Margherita Rimini, Lorenza Rimassa, Kazuomi Ueshima, Valentina Burgio, S. Shigeo, Toshifumi Tada, Goki Suda, Chi‐Hyeon Yoo, Jaekyung Cheon, David J. Pinato, Sara Lonardi, Mario Scartozzi, Massimo Iavarone, G.G. Di Costanzo, Fabio Marra, Caterina Soldà, Emiliano Tamburini, Fabio Piscaglia, Gianluca Masi, Giuseppe Cabibbo, Francesco Giuseppe Foschi, Marianna Silletta,
Discussion(0)
No comments yet. Be the first to comment.